Vote Scores
Filings read through

UroGen Pharma Ltd.: how funds voted at the meeting of 6 Aug 2024

Ticker
URGN
Meeting
Season
year to 30 June 2025
Filers reporting
173
Ballot items
4

173 filers on Form N-PX reported votes at the UroGen Pharma Ltd. meeting of 6 Aug 2024. The records fall into 4 ballot items. The page lists them in ballot order: items of the company first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting.

This meeting is in the year to 30 June 2025. The latest season on file is the year to 30 June 2026. The page of UroGen Pharma Ltd. has the latest meeting.

If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.

The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .

The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.

The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.

The page gives records. It gives no investment advice and no advice on how to vote.

Season on this page: year to 30 June 2025. Filings read through . How the figures are made

The ballot

ForAgainstAbstain, withhold or otherAmber tick: the part cast against management

  1. Item 1: Director elections

    8 nominees. 90.7% of the reported votes are for. 27 filers withheld from or voted against at least one nominee.

    712 vote records from 53 filers. 0 of the 52 filers that marked the item voted against management. 1 filer gave no management mark.

    • Positions of 24 fund families
    • For 24
  2. Item 2: Advisory vote on executive pay (say-on-pay)

    250 vote records from 172 filers. 14 of the 164 filers that marked the item voted against management. 8 filers gave no management mark.

    • Positions of 31 fund families
    • For 30
    • Against 1
    • Against management 1
  3. Item 3: Audit-related items (auditor ratification)

    89 vote records from 53 filers. 0 of the 52 filers that marked the item voted against management. 1 filer gave no management mark.

    • Positions of 24 fund families
    • For 24
  4. Item 4: COMPENSATION: management items

    The company's items in this category are shown together, because filers word and number them differently.

    173 vote records from 55 filers. 0 of the 54 filers that marked the item voted against management. 1 filer gave no management mark.

    • Positions of 24 fund families
    • For 21
    • Split or no vote 3

Positions of the fund families

A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.

KeyForAgainstAbstain or withholdSplit or no voteAgainst management

Fund families at UroGen Pharma Ltd., meeting of 6 Aug 2024Families in name order. "Abstain" includes withhold. "Split" includes no vote. "No report" means that no filer of the family listed the item.
Fund family2. Say-on-pay3. Auditor
AllianceBernsteinForNo report
AllspringForNo report
BlackRock and iSharesForFor
BNY MellonForNo report
Brighthouse FundsForFor
Charles SchwabForFor
Columbia ThreadneedleForNo report
DWSForFor
EquitableForFor
FidelityForFor
Global XForFor
Goldman SachsForFor
Guggenheim and RydexForFor
InvescoAgainst, against managementNo report
J.P. MorganForNo report
John Hancock and ManulifeForFor
Lincoln FinancialForFor
Morgan Stanley, Eaton Vance and CalvertForFor
NationwideForFor
Neuberger BermanForNo report
Northern Trust and FlexSharesForFor
Nuveen and TIAAForFor
Pacific Life fundsForFor
PGIM and PrudentialForFor
PrincipalForFor
ProShares and ProFundsForFor
SEIForFor
State Street and SPDRForFor
T. Rowe PriceForFor
VanguardForFor
VoyaForFor

Questions

How many filers reported votes at the UroGen Pharma Ltd. meeting?
173 Form N-PX filers reported votes at the meeting of 6 Aug 2024. On say-on-pay, 14 of 164 filers that marked the item voted against management (8.5%).
Is this the result of the meeting?
No. The page counts the filers that report on Form N-PX, and the shares they reported. UroGen Pharma Ltd. reports the result of a vote on Form 8-K.
Why does the page show counts only for director elections?
A director record names the nominee. This site has no page and no row about a person. For director elections it keeps the number of nominees and the split of votes.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list UroGen Pharma Ltd. with a meeting date within three days of 6 Aug 2024. A proposal title is the most common wording among filers. Where a wording can name a person, the SEC category is shown. The filers wrote the filings. Filings read through .